Data, Machine Learning,
and Experimentation
MEET ELION:
a new type of platform for phenotypic drug discovery.
We integrate clinical and experimental data using machine learning to translate human disease biology and advance precision medicines.
We acquire data from clinical, pharmaceutical and genomics partners, integrate it with machine learning, and validate findings using human disease relevant experimental models.
Data +
Machine Learning +Experimentation
-
We have unique access to more than 77 million longitudinal patient records, over 1 million genomic profiles, millions of experimental assays, and billions of chemical structure connections.
-
Our patented Contingent AI™ understands relationships within the data to provide sophisticated insights.
We address data bias by iterating on machine learning models based upon decisions made in the pre-processing and feature engineering stages.
-
We leverage zebrafish, cellular and other phenotypic animal models to validate in silico predictions in vivo experiments and genetically modify them in vitro and in vivo, to improve translation.
Using active learning and computer vision on validated models for cardiac, central nervous system and rare disorders, we rapidly incorporate new data into our machine learning models.
Interested in Partnering?
We seek partners with both a desire to transform drug discovery and access to rich patient data, whether it’s EMR data, genomics data or clinical trial data. We are also seeking partners to help advance our drug discovery programs in cardiac, neurodegenerative and rare diseases.
We are highly collaborative experts in machine learning, data science and drug discovery. Let’s chat.